Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial

Triple hormone drug retatrutide shows promise for diabetes and weight loss in Lancet trial

A new triple hormone drug called retatrutide, which mimics GLP-1, GIP, and glucagon, has shown promising results in a Lancet-published trial

Network Meta-Analysis Identifies Optimal Exercise Modalities and Doses for Blood Pressure Reduction in Hypertensive Adults

This study conducted a Bayesian network meta-analysis and dose-response modeling of 105 randomized controlled trials (published up to April

Farxiga Affordability Tips: From Discount Cards to Patient Assistance

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals - Nature Metabolism

Statins and blood pressure drugs changing health risks of obesity, study suggests

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica